IHE
iShares U.S. Pharmaceuticals ETF
1W: +0.2%
1M: -6.8%
3M: -0.1%
YTD: +0.5%
1Y: +24.5%
3Y: +54.5%
5Y: +55.5%
$85.27
-0.75 (-0.87%)
After Hours: $87.66 (+2.39, +2.81%)
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Weather
ETF-Level Metrics
AUM$661M
Holdings53
Top 10 Wt80.2%
Beta0.66
% Profitable45%
Coverage99%
Portfolio Valuation
P/E27.5
P/B8.1
P/S7.4
EV/EBITDA19.8
P/FCF39.6
PEG0.68
Profitability & Returns
Gross Margin83.4%
Net Margin26.6%
ROE34.3%
ROA12.8%
ROIC20.1%
Div Yield1.72%
Leverage & Liquidity
Debt/Equity0.71
Debt/Assets0.28
Net Debt/EBITDA1.0x
Interest Cov21.9x
Current Ratio1.31
Quick Ratio1.01
Growth (YoY)
Revenue+19.6%
Net Income+47.3%
EPS+48.9%
FCF+38.9%
EBITDA+40.4%
Rev CAGR 3Y+16.1%
Quality Scores
Piotroski F6.0
Altman Z5.87
IS Quality67.7
IS Overall58.8
IS Value45.5
Median P/E-4.0
Sector Breakdown
2 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 53 | 99.9% | 27.2 |
| Other | 3 | 0.1% | — |
Smart Money Overlap
3 holdings with signals
Showing 50 of 56 holdings
· Page 1 of 2
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | JOHNSON & JOHNSON | JNJ | 25.26% | $247.2M | 1,041,925 | 21.7 | $576.5B | Healthcare |
| 2 | ELI LILLY | LLY | 20.32% | $198.8M | 216,577 | 39.0 | $847.1B | Healthcare |
| 3 | MERCK & CO INC | MRK | 5.16% | $50.5M | 440,891 | 16.2 | $294.1B | Healthcare |
| 4 | BRISTOL MYERS SQUIBB | BMY | 5.10% | $49.9M | 840,457 | 17.2 | $121.0B | Healthcare |
| 5 | ROYALTY PHARMA PLC CLASS A | RPRX | 4.67% | $45.7M | 998,312 | 26.3 | $20.1B | Healthcare |
| 6 | PFIZER INC | PFE | 4.66% | $45.6M | 1,669,504 | 20.2 | $156.7B | Healthcare |
| 7 | ZOETIS INC CLASS A | ZTS | 4.37% | $42.8M | 364,528 | 19.1 | $51.4B | Healthcare |
| 8 | VIATRIS INC | VTRS | 4.29% | $42.0M | 3,058,230 | -4.4 | $15.4B | Healthcare |
| 9 | ELANCO ANIMAL HEALTH INC | ELAN | 3.35% | $32.8M | 1,319,292 | -52.6 | $12.2B | Healthcare |
| 10 | JAZZ PHARMACEUTICALS PLC | JAZZ | 2.98% | $29.1M | 161,346 | -32.4 | $11.6B | Healthcare |
| 11 | AXSOME THERAPEUTICS INC | AXSM | 1.81% | $17.8M | 112,441 | -45.4 | $8.4B | Healthcare |
| 12 | TERNS PHARMACEUTICALS INC | TERN | 1.12% | $10.9M | 228,689 | -51.6 | $4.8B | Healthcare |
| 13 | LIGAND PHARMACEUTICALS INC | LGND | 1.12% | $10.9M | 52,261 | 32.3 | $4.1B | Healthcare |
| 14 | INDIVIOR PHARMACEUTICALS INC | INDV | 1.03% | $10.1M | 331,518 | 17.8 | $3.7B | Healthcare |
| 15 | CRINETICS PHARMACEUTICALS INC | CRNX | 1.00% | $9.8M | 272,194 | -7.3 | $3.8B | Healthcare |
| 16 | CORCEPT THERAPEUTICS INC | CORT | 0.85% | $8.3M | 248,577 | 40.4 | $4.1B | Healthcare |
| 17 | PRESTIGE CONSUMER HEALTHCARE INC | PBH | 0.79% | $7.8M | 127,675 | 15.5 | $2.9B | Healthcare |
| 18 | SUPERNUS PHARMACEUTICALS INC | SUPN | 0.77% | $7.5M | 152,249 | -75.6 | $2.9B | Healthcare |
| 19 | TARSUS PHARMACEUTICALS INC | TARS | 0.72% | $7.1M | 103,695 | -43.3 | $2.9B | Healthcare |
| 20 | LIQUIDIA CORP | LQDA | 0.68% | $6.7M | 182,484 | -46.5 | $3.2B | Healthcare |
| 21 | EDGEWISE THERAPEUTICS INC | EWTX | 0.60% | $5.8M | 196,774 | -19.4 | $3.4B | Healthcare |
| 22 | AMNEAL PHARMACEUTICALS INC CLASS A | AMRX | 0.57% | $5.6M | 450,744 | 52.4 | $3.8B | Healthcare |
| 23 | NEKTAR THERAPEUTICS | NKTR | 0.54% | $5.2M | 71,546 | -8.8 | $1.4B | Healthcare |
| 24 | WAVE LIFE SCIENCES LTD | WVE | 0.47% | $4.6M | 383,808 | -5.5 | $1.2B | Healthcare |
| 25 | DEFINIUM THERAPEUTICS INC | DFTX | 0.47% | $4.6M | 261,565 | — | $1.9B | Healthcare |
| 26 | ORGANON | OGN | 0.44% | $4.3M | 690,318 | 8.4 | $1.6B | Healthcare |
| 27 | INNOVIVA INC | INVA | 0.42% | $4.1M | 188,603 | 6.3 | $1.5B | Healthcare |
| 28 | OCULAR THERAPEUTIX INC | OCUL | 0.39% | $3.8M | 452,553 | -6.8 | $1.8B | Healthcare |
| 29 | PERRIGO PLC | 0Y5E.L | 0.37% | $3.6M | 365,425 | -0.9 | $1.3B | Healthcare |
| 30 | ANI PHARMACEUTICALS INC | ANIP | 0.36% | $3.5M | 47,734 | 19.6 | $1.7B | Healthcare |
| 31 | ENLIVEN THERAPEUTICS INC | ELVN | 0.33% | $3.2M | 118,186 | -21.5 | $2.3B | Healthcare |
| 32 | AMYLYX PHARMACEUTICALS INC | AMLX | 0.31% | $3.1M | 221,588 | -8.8 | $1.1B | Healthcare |
| 33 | HARROW INC | HROW | 0.31% | $3.0M | 87,521 | -253.1 | $1.3B | Healthcare |
| 34 | TREVI THERAPEUTICS INC | TRVI | 0.30% | $2.9M | 275,738 | -40.2 | $1.5B | Healthcare |
| 35 | HARMONY BIOSCIENCES HLDG INC | HRMY | 0.30% | $2.9M | 105,490 | 10.0 | $1.6B | Healthcare |
| 36 | COLLEGIUM PHARMACEUTICAL INC | COLL | 0.30% | $2.9M | 83,905 | 16.9 | $1.1B | Healthcare |
| 37 | PHIBRO ANIMAL HEALTH CORP CLASS A | PAHC | 0.29% | $2.8M | 54,287 | 24.6 | $2.3B | Healthcare |
| 38 | EYEPOINT INC | EYPT | 0.29% | $2.8M | 206,515 | -4.7 | $1.1B | Healthcare |
| 39 | NUVATION BIO INC CLASS A | NUVB | 0.28% | $2.7M | 636,953 | -7.4 | $1.5B | Healthcare |
| 40 | MAZE THERAPEUTICS INC | MAZE | 0.28% | $2.7M | 56,218 | -10.4 | $1.5B | Healthcare |
| 41 | PACIRA BIOSCIENCES INC | PCRX | 0.26% | $2.5M | 114,223 | 140.8 | $1.0B | Healthcare |
| 42 | XERIS BIOPHARMA HOLDINGS INC | XERS | 0.24% | $2.4M | 440,336 | 1668.6 | $960M | Healthcare |
| 43 | OMEROS CORP | OMER | 0.21% | $2.1M | 188,178 | -5.6 | $730M | Healthcare |
| 44 | RAPPORT THERAPEUTICS INC | RAPP | 0.21% | $2.0M | 75,984 | -12.2 | $1.1B | Healthcare |
| 45 | MBX BIOSCIENCES INC | MBX | 0.20% | $1.9M | 66,749 | -11.9 | $950M | Healthcare |
| 46 | ARVINAS INC | ARVN | 0.19% | $1.9M | 170,640 | -8.7 | $698M | Healthcare |
| 47 | AMPHASTAR PHARMACEUTICALS INC | AMPH | 0.18% | $1.8M | 93,893 | 9.1 | $897M | Healthcare |
| 48 | SEPTERNA INC | SEPN | 0.15% | $1.5M | 60,819 | -22.4 | $1.1B | Healthcare |
| 49 | THERAVANCE BIOPHARMA INC | TBPH | 0.14% | $1.4M | 98,352 | 7.3 | $776M | Healthcare |
| 50 | PHATHOM PHARMACEUTICALS INC | PHAT | 0.14% | $1.3M | 120,844 | -3.6 | $850M | Healthcare |